Normalization of lipid oxidation defects arising from hypoxia early posthepatectomy prevents liver failure in mouse
Dominique Lisa Birrer(University Hospital Zurich), Bostjan Humar(University Hospital of Zurich), Lucía Bautista Borrego(University Hospital Zurich), Ekaterina Kachaylo(University Hospital Zurich), Thorsten Hornemann(University Hospital of Zurich), Philipp Kron(University Hospital Zurich), R. Steiner(University Hospital Zurich), Carola Kälin(University of Zurich), Pierre‐Alain Clavien(University Hospital of Zurich), Catherine Hagedorn(University Hospital Zurich), Michael Linecker(University Hospital of Zurich), Jean‐François Dufour(Universidad Iberoamericana), Eva Breuer(University Hospital of Zurich), U. Ungethüm(University Hospital Zurich), Michelangelo Foti(University Hospital of Geneva)
Cited by 10
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline <i>CDH1</i> mutation carriers
|Journal of Medical Genetics|2015|567
cHCC‐CCA
|Hepatology|2018|333
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
|Journal of Hepatology|2021|309
Serotonin promotes tumor growth in human hepatocellular cancer†
|Hepatology|2009|214